A phase 2 trial of sunitinib in patients with advanced non-clear cell renal cell carcinoma

BACKGROUND: Sunitinib is a standard of care treatment in advanced clear-cell renal cell carcinoma (ccRCC). Retrospective and expanded access data suggest sunitinib has activity in advanced non-clear cell RCC (nccRCC). OBJECTIVE: To prospectively determine the clinical efficacy and safety of sunitini...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Tannir, Nizar M., Plimack, Elizabeth, Ng, Chaan, Tamboli, Pheroze, Bekele, Neby, Xiao, Lianchun, Smith, Lisa, Lim, Zita, Pagliaro, Lance, Araujo, John, Aparicio, Ana, Matin, Surena, Wood, Christopher G, Jonasch, Eric
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2012
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3882163/
https://ncbi.nlm.nih.gov/pubmed/22771265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2012.06.043
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items